-
2022-07-17MY004567 tablets was approved by the FDA US. for clinical trials implied
-
2022-04-29Dr. Jing Zhang, formerly Head of the Clinical Team at the FDA's Center for Drug Approval, serves as CMO of Createrna
-
2022-02-16The application for clinical trial of MY008211A tablet was officially accepted by the State Food and Drug Administration
-
2021-08-11MY004567 tablets was clinically approved by FDS
-
2020-11-04Createrna was invited to participate in the Chinese Pharmaceutical Innovation Investment Forum
- 1